Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

LightPath Technologies, Inc. (LPTH) Reports Q3 Loss, Misses Revenue Estimates
LightPath Technologies, Inc. (LPTH) Reports Q3 Loss, Misses Revenue Estimates

LightPath Technologies, Inc. (LPTH) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.07 per share a year ago

Take-Two Interactive (TTWO) Q4 Earnings and Revenues Beat Estimates
Take-Two Interactive (TTWO) Q4 Earnings and Revenues Beat Estimates

Take-Two Interactive (TTWO) came out with quarterly earnings of $1.09 per share, beating the Zacks Consensus Estimate of $1.08 per share. This compares to earnings of $0.31 per share a year ago

P3 Health Partners Inc. (PIII) Reports Q1 Loss, Tops Revenue Estimates
P3 Health Partners Inc. (PIII) Reports Q1 Loss, Tops Revenue Estimates

P3 Health Partners Inc. (PIII) came out with a quarterly loss of $6.28 per share versus the Zacks Consensus Estimate of a loss of $5. This compares to loss of $8 per share a year ago. These figures

Cava Group (CAVA) Surpasses Q1 Earnings and Revenue Estimates
Cava Group (CAVA) Surpasses Q1 Earnings and Revenue Estimates

Cava Group (CAVA) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.12 per share a year ago. These figures

Duos Technologies Group, Inc. (DUOT) Reports Q1 Loss, Tops Revenue Estimates
Duos Technologies Group, Inc. (DUOT) Reports Q1 Loss, Tops Revenue Estimates

Duos Technologies Group, Inc. (DUOT) came out with a quarterly loss of $0.18 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.38 per share a year ago. These figures

Fortress Biotech (FBIO) Reports Q1 Loss, Tops Revenue Estimates
Fortress Biotech (FBIO) Reports Q1 Loss, Tops Revenue Estimates

Fortress Biotech (FBIO) came out with a quarterly loss of $0.48 per share versus the Zacks Consensus Estimate of a loss of $0.44. This compares to loss of $1.03 per share a year ago. These figures

PLBY Group, Inc. (PLBY) Reports Q1 Loss, Tops Revenue Estimates
PLBY Group, Inc. (PLBY) Reports Q1 Loss, Tops Revenue Estimates

PLBY Group, Inc. (PLBY) came out with a quarterly loss of $0.10 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.23 per share a year ago. These figures are adjusted

Sensus Healthcare, Inc. (SRTS) Reports Q1 Loss, Tops Revenue Estimates
Sensus Healthcare, Inc. (SRTS) Reports Q1 Loss, Tops Revenue Estimates

Sensus Healthcare, Inc. (SRTS) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of $0.04. This compares to earnings of $0.14 per share a year ago. These figures

Quantum-Si Incorporated (QSI) Reports Q1 Loss, Lags Revenue Estimates
Quantum-Si Incorporated (QSI) Reports Q1 Loss, Lags Revenue Estimates

Quantum-Si Incorporated (QSI) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to loss of $0.14 per share a year ago. These

Dragonfly Energy Holdings Corp. (DFLI) Reports Q1 Loss, Tops Revenue Estimates
Dragonfly Energy Holdings Corp. (DFLI) Reports Q1 Loss, Tops Revenue Estimates

Dragonfly Energy Holdings Corp. (DFLI) came out with a quarterly loss of $1.45 per share versus the Zacks Consensus Estimate of a loss of $1.44. This compares to loss of $1.53 per share a year ago

Legacy Education Inc. (LGCY) Tops Q3 Earnings and Revenue Estimates
Legacy Education Inc. (LGCY) Tops Q3 Earnings and Revenue Estimates

Legacy Education Inc. (LGCY) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.19 per share a year ago

Virgin Galactic (SPCE) Reports Q1 Loss, Tops Revenue Estimates
Virgin Galactic (SPCE) Reports Q1 Loss, Tops Revenue Estimates

Virgin Galactic (SPCE) came out with a quarterly loss of $2.38 per share versus the Zacks Consensus Estimate of a loss of $2.23. This compares to loss of $5 per share a year ago. These figures are

Marvell Vs Micron Technology: Which AI Chip Stock is the Better Investment
Marvell Vs Micron Technology: Which AI Chip Stock is the Better Investment

With global trade fears subsiding, market sentiment has turned rather bullish again, and investors may be eyeing the stocks of up-and-coming AI chip providers like Marvell Technology MRVL and Micron

Applied Materials (AMAT) Surpasses Q2 Earnings Estimates
Applied Materials (AMAT) Surpasses Q2 Earnings Estimates

Applied Materials (AMAT) came out with quarterly earnings of $2.39 per share, beating the Zacks Consensus Estimate of $2.31 per share. This compares to earnings of $2.09 per share a year ago. These

Gossamer Bio (GOSS) Reports Q1 Loss, Tops Revenue Estimates
Gossamer Bio (GOSS) Reports Q1 Loss, Tops Revenue Estimates

Gossamer Bio (GOSS) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.19 per share a year ago. These figures are

Doximity (DOCS) Surpasses Q4 Earnings and Revenue Estimates
Doximity (DOCS) Surpasses Q4 Earnings and Revenue Estimates

Doximity (DOCS) came out with quarterly earnings of $0.38 per share, beating the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.25 per share a year ago. These figures

ESS Tech, Inc. (GWH) Reports Q1 Loss, Lags Revenue Estimates
ESS Tech, Inc. (GWH) Reports Q1 Loss, Lags Revenue Estimates

ESS Tech, Inc. (GWH) came out with a quarterly loss of $1.50 per share versus the Zacks Consensus Estimate of a loss of $1.66. This compares to loss of $1.50 per share a year ago. These figures are

Top Research Reports for AMD, Union Pacific & Lowe's
Top Research Reports for AMD, Union Pacific & Lowe's

Thursday, May 15, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Advanced

The Case for Buying NVIDIA Right Now
The Case for Buying NVIDIA Right Now

Welcome to Episode #444 of the Zacks Market Edge Podcast.

Every week, host and Zacks stock strategist, Tracey Ryniec, will be joined by guests to discuss the hottest investing topics in stocks

Bullish Case for These Energy Stocks: GLP, NFG, EPSN
Bullish Case for These Energy Stocks: GLP, NFG, EPSN

Energy stocks are beginning to reassert their strength as macro conditions improve and demand drivers multiply. With recession fears easing as tariff negotiations show signs of progress, the market

UnitedHealth Stock: Justice Department Probe Triggers Freefall
UnitedHealth Stock: Justice Department Probe Triggers Freefall

UnitedHealth Group finds itself in severe turmoil as shares plummeted nearly 11% to $245.90 following news of a U.S. Justice Department criminal investigation into potential Medicare fraud. The

Uber Stock: Analysts Bullish Despite Consumer Hesitation
Uber Stock: Analysts Bullish Despite Consumer Hesitation

Despite recent mixed signals in the ride-sharing and delivery giant's performance, Uber's stock climbed nearly 10% last week, approaching its 52-week high of $92.17. While Q1 gross bookings

Energiekontor Stock: Supply Chain Woes Imperil Growth Targets
Energiekontor Stock: Supply Chain Woes Imperil Growth Targets

The Bremen-based wind and solar park developer Energiekontor is facing significant headwinds that have made investors noticeably nervous. The company is grappling with substantial delays in

After 92% YTD Surge, Is Tempus AI a Buy on Trump's Executive Order?
After 92% YTD Surge, Is Tempus AI a Buy on Trump's Executive Order?

Tempus AI TEM, an innovator in artificial intelligence-based healthcare solutions, has been attracting investors' interest since its successful initial public offering in June 2024. The stock has

Meta Platforms vs. Microsoft: Which AI Superpower is a Better Buy?
Meta Platforms vs. Microsoft: Which AI Superpower is a Better Buy?

Meta Platforms META and Microsoft MSFT have evolved as artificial intelligence (AI) powerhouses with significant investments in developing AI infrastructure and applications. While Meta Platform